Arkolith/Insider Trading/RVLP/Form 4

Markison Brian A

Chief Executive Officer, DirectorRVL Pharmaceuticals plc (RVLP) · full profile →Form 4 · filed Aug 9, 2022
Net Buying
Open-Market Buys
$1.3M
Open-Market Sells
$0
Net Open-Market Flow
$1.3M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2022Buy(P)850K$1.55$1.3M3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-088034) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML